Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 300,100 shares, an increase of 336.8% from the April 30th total of 68,700 shares. Based on an average daily volume of 1,147,800 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the company's stock are sold short.
Reckitt Benckiser Group Stock Up 1.4%
RBGLY traded up $0.19 during trading hours on Friday, hitting $13.66. 207,116 shares of the company's stock were exchanged, compared to its average volume of 385,246. Reckitt Benckiser Group has a 1-year low of $10.43 and a 1-year high of $14.10. The stock's 50-day moving average is $13.04 and its two-hundred day moving average is $12.82. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69.
Reckitt Benckiser Group Increases Dividend
The firm also recently announced a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be issued a dividend of $0.2909 per share. This is a boost from Reckitt Benckiser Group's previous dividend of $0.19. The ex-dividend date of this dividend is Friday, April 11th.
Analyst Upgrades and Downgrades
Several research analysts recently commented on RBGLY shares. Barclays cut shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a report on Tuesday, February 4th. Royal Bank of Canada restated an "outperform" rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th. Three research analysts have rated the stock with a hold rating, two have given a buy rating and three have issued a strong buy rating to the company. According to MarketBeat.com, Reckitt Benckiser Group has an average rating of "Buy".
Get Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
